Prion Disease Treatment Market: How Are Antisense Oligonucleotides and Immunotherapy Approaches Offering Hope Against Invariably Fatal Neurodegeneration?
Prion diseases — the transmissible spongiform encephalopathies including Creutzfeldt-Jakob disease, variant CJD, fatal familial insomnia, and Gerstmann-Sträussler-Scheinker syndrome — have long been considered the most hopeless of neurodegenerative conditions with one hundred percent mortality and median survival of four to six months for sporadic CJD, but the Prion Disease...
0 Comments 0 Shares 72 Views 0 Reviews
Sponsored
Sponsored